Intellipharmaceutics International Inc. (IPCI)

[J_Cali]

I hear ya....so much for the NDA submission PR we have identified or evaluating manufacturer options...don't remember exact wording

My cut and paste left out pg206 text..... DPV identified three foreign cases of TMA associated with intravenous abuse of OxyContin, which also contains a PEO polymer; however, no U.S. cases were identified.

There might be a few articles about OxyContin on Internet and TMA but is no where near the opana TMA issues.

I actual wish we would cut the R&D budget in half until we get rexista approved and built up $10m in cash but that's get my 2 cents. I have seen other companies get a little ahead of themselves.

Coreg was listed as in late stage develoment 6 years ago are we really spending hours working on a generic for a product with less than $300m.